MindMaze and The University of Auckland Partner on Novel Early Intervention Study for Stroke Patients, Expanding Global Breadth of Research Supporting the Company's Brain Tech Solutions
yahoo.com
news
2022-06-01 13:08:00

BALTIMORE & LAUSANNE, Switzerland & AUCKLAND, New Zealand, June 01, 2022--(BUSINESS WIRE)--MindMaze, a category-defining global leader in digital therapeutics (DTx) for neurological recovery and care, in partnership with The University of Auckland, today announced a new interventional study that will aim to show the merits of early, immersive, and intensive intervention to recover movement for patients who have experienced a stroke. The Phase 2 trial, Enhancing Spontaneous Recovery After Stroke Study (ESPRESSo, ACTRN12620000871943), will evaluate the effect of the use of MindPod in a three-week program of high-intensity, high-dose exploratory arm and hand movements initiated within two weeks of stroke on upper limb motor capacity.
